PUTRAJAYA, July 30 — The Health Ministry (MOH) has issued an order to all shops selling ice cream laced with a traditional cough syrup ‘Pei Pa Koa’ (Cap Ibu dan Anak) to immediately stop selling the prohibited concoction, to protect consumers and public health.

KUALA LUMPUR, May 1 — A cough syrup product, Guaifenesin Syrup TG Syrup, manufactured by QP Pharmachem Ltd.

NEW YORK, Jan 24 — The World Health Organisation (WHO) on Monday called on authorities to carry out stronger checks after life-threatening cough syrups for children appeared in at least seven countries.

JAKARTA, Jan 19 — Families of Indonesian children who died because of tainted cough syrup demanded restitution as an Indonesian court on Tuesday started hearing their class-action lawsuit against government agencies and pharmaceutical firms.

NEW DELHI, Dec 30 — All manufacturing activities have been halted at a facility of Indian drugmaker Marion Biotech, which has been linked to child deaths due to cough syrup consumption in Uzbekistan.

MOSCOW, Dec 29 — The Indian authorities launched an investigation into the pharmaceutical company Marion Biotech, based in the northern state of Uttar Pradesh, after 18 children died In Uzbekistan as a result of consuming the company’s drugs, Indian media reported on Thursday.

JAKARTA, Nov 1 — Indonesia's food and drug agency said on Monday it had revoked licences for syrup-type drug production by two local firms for violating manufacturing rules, as it investigates the deaths of more than 150 children due to acute kidney injury (AKI).

JAKARTA, Oct 21 — Some medicinal syrups available in Indonesia contained ingredients linked to fatal acute kidney injury (AKI) in children, its health minister said on Thursday, as it investigates a spike in cases and 99 child deaths this year.

KUALA LUMPUR, Oct 7 — The four cough and cold syrup products produced by Maiden Pharmaceuticals in India, which were linked to the death of 66 children in Gambia, are not registered in Malaysia, said Health director-General Tan Sri Dr Noor Hisham Abdullah.